The investigator initiated Phase I trial of ADRCs (Cytori Cell Therapy™) in the patients with post prostatectomy erectile dysfunction.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 18 May 2017
At a glance
- Drugs ECCS 50 (Primary)
- Indications Erectile dysfunction
- Focus Adverse reactions
- 18 May 2017 New trial record
- 10 May 2017 According to a Cytori Therapeutics Media Release, data will be presented occur at the 2017 American Urological Association Annual Meeting, and the abstract is currently available in the Journal of Urology (online).
- 10 May 2017 According to a Cytori Therapeutics Media Release, six month follow-up data (n=17) from this trial published in EBioMedicine journal.